Related Experiment Video
Updated: Jul 2, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Clinical and echocardiographic findings in patients with COVID-19 across different severity levels
Ihor Hryzhak1, Oleksandra Pryshliak1, Taras Kobryn1
1Infectious Diseases and Epidemiology Department, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine.
Echocardiographic abnormalities like reduced ejection fraction and pulmonary hypertension are linked to severe COVID-19. These cardiac issues, along with chronic heart failure, predict worse outcomes and mortality in COVID-19 patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- COVID-19 can lead to cardiovascular complications.
- Understanding cardiac involvement is crucial for predicting COVID-19 severity and outcomes.
Purpose of the Study:
- To identify echocardiographic abnormalities in COVID-19 patients.
- To determine key prognostic factors for severe and fatal COVID-19 outcomes.
Main Methods:
- Retrospective cohort study of 194 hospitalized COVID-19 patients.
- Analysis of clinical and echocardiogram data.
- Comparison of moderate, severe (favorable outcome), and severe (fatal outcome) groups.
Main Results:
- Severe COVID-19 with favorable outcomes showed reduced left ventricular ejection fraction and diastolic dysfunction compared to moderate cases.
- Fatal COVID-19 cases exhibited significantly decreased left ventricular ejection fraction, myocardial dysfunction, and a trend towards pulmonary hypertension compared to severe cases with favorable outcomes.
- Key cardiac risk factors for severe COVID-19 progression and mortality included chronic heart failure, reduced left ventricular ejection fraction, myocardial dysfunction, and pulmonary hypertension.
Conclusions:
- Echocardiographic findings are vital indicators of COVID-19 severity.
- Chronic heart failure, reduced left ventricular ejection fraction, myocardial dysfunction, and pulmonary hypertension are significant predictors of poor prognosis in COVID-19.
- Targeting these cardiac factors may improve management of severe COVID-19.
Related Concept Videos
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Cardiovascular System Abnormal Findings II: Auscultation
Abnormal Heart Sounds
Gallops:

